AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE1370.2518.8 (+1.39 %)
PREV CLOSE ( ) 1351.45
OPEN PRICE ( ) 1370.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1370.25 (190)
VOLUME 10371
TODAY'S LOW / HIGH ( )1358.60 1376.00
52 WK LOW / HIGH ( )1106 1870
NSE1374.4524.15 (+1.79 %)
PREV CLOSE( ) 1350.30
OPEN PRICE ( ) 1368.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1374.45 (313)
VOLUME 149023
TODAY'S LOW / HIGH( ) 1359.05 1378.45
52 WK LOW / HIGH ( )1120.05 1852.95
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 31-12 1979
Management Info
Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director
Registered Office

Address Ajanta House,Charkop ,Kandivali (W),
Mumbai,
Maharashtra-400067

Phone 91-22-66061000

Email info@ajantapharma.com

Website www.ajantapharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
16Feb Announcement under Regulation 30 (LOD
This is to inform you that our formulation facility at Dahej was inspect..
15Dec Updates
Change in designation of a Director We wish to inform you that the co..
15Dec Updates
Change in designation of a Director We wish to inform you that the co..
22Nov NCC, Ajanta Pharma and Virinchi to see
The consortium formed between NCC & BGR Infra has been awarded the p..
21Nov Ajanta Pharma launches Clonidine Hydro
Ajanta Pharma has launched Clonidine Hydrochloride Extended Release Tabl..
Financials
Rs. in Millions
QTR Dec 17 ANNUAL 17
Net Profit1645.94998.1
Gross Profit 2038.3 6406.5
Operating Profit 2182.77029.6
Net Sales 5007.818227.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddys Lab (BSE)
 2169.25 (2.26%)
M.Cap (Rs. in Cr)35986.45
Merck (BSE)
 1486.60 (2.96%)
M.Cap (Rs. in Cr)2467.66
Abbott India (BSE)
 5788.40 (0.72%)
M.Cap (Rs. in Cr)12299.95
Zandu Realty (BSE)
 1993.80 (1.95%)
M.Cap (Rs. in Cr)160.78
Piramal Enterprises (BSE)
 2622.05 (1.31%)
M.Cap (Rs. in Cr)47275.73
Shareholding Pattern
PROMOTERS 70.7%
NON-INSTITUTION 10.66%
MUTUAL FUNDS/UTI 5.6%
FI/BANKS/INSURANCE 0.18%
GOVERNMENT 0.03%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.